CY1122525T1 - Μεθοδοι θεραπειας μιας πνευμονικης βακτηριακης λοιμωξης με τη χρησιμοποιηση φθορο-κινολονων - Google Patents
Μεθοδοι θεραπειας μιας πνευμονικης βακτηριακης λοιμωξης με τη χρησιμοποιηση φθορο-κινολονωνInfo
- Publication number
- CY1122525T1 CY1122525T1 CY20191101155T CY191101155T CY1122525T1 CY 1122525 T1 CY1122525 T1 CY 1122525T1 CY 20191101155 T CY20191101155 T CY 20191101155T CY 191101155 T CY191101155 T CY 191101155T CY 1122525 T1 CY1122525 T1 CY 1122525T1
- Authority
- CY
- Cyprus
- Prior art keywords
- methods
- treating
- bacterial infection
- fluoroquinolones
- pulmonary bacterial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Abstract
Εδώ αποκαλύπτονται μέθοδοι θεραπείας μιας πνευμονικής βακτηριακής λοίμωξης που περιλαμβάνει βακτήρια αναπτυσσόμενα υπό αναερόβιες συνθήκες με τη χρησιμοποίηση ενός αντιβιοτικού φθοροκινολόνης. Το αντιβιοτικό φθοροκινολόνης μπορεί, για παράδειγμα, να είναι λεβοφλοξασίνη ή οφλοξασίνη. Επίσης αποκαλύπτονται μέθοδοι αναστολής βακτηρίων που αναπτύσσονται υπό αναερόβιες συνθήκες με έκθεση των βακτηρίων σε μια ποσότητα αντιβιοτικού φθοροκινολόνης αποτελεσματικού για την αναστολή της ανάπτυξης των ρηθέντων βακτηρίων.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17262509P | 2009-04-24 | 2009-04-24 | |
PCT/US2010/032128 WO2010124141A1 (en) | 2009-04-24 | 2010-04-22 | Methods of treating a pulmonary bacterial infection using fluoro-quinolones |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1122525T1 true CY1122525T1 (el) | 2021-01-27 |
Family
ID=43011488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20191101155T CY1122525T1 (el) | 2009-04-24 | 2019-11-06 | Μεθοδοι θεραπειας μιας πνευμονικης βακτηριακης λοιμωξης με τη χρησιμοποιηση φθορο-κινολονων |
Country Status (27)
Country | Link |
---|---|
US (2) | US20120035166A1 (el) |
EP (1) | EP2421539B1 (el) |
JP (2) | JP6179844B2 (el) |
KR (1) | KR20120034626A (el) |
CN (2) | CN102427815A (el) |
AU (1) | AU2010238765B2 (el) |
BR (1) | BRPI1006626B8 (el) |
CA (1) | CA2759874C (el) |
CL (1) | CL2011002649A1 (el) |
CO (1) | CO6450642A2 (el) |
CY (1) | CY1122525T1 (el) |
DK (1) | DK2421539T3 (el) |
ES (1) | ES2755754T3 (el) |
HR (1) | HRP20191951T1 (el) |
HU (1) | HUE046595T2 (el) |
IL (1) | IL215777A (el) |
LT (1) | LT2421539T (el) |
MX (1) | MX339077B (el) |
MY (1) | MY178871A (el) |
NZ (1) | NZ596245A (el) |
PL (1) | PL2421539T3 (el) |
PT (1) | PT2421539T (el) |
RU (1) | RU2535056C2 (el) |
SG (3) | SG10201811494SA (el) |
SI (1) | SI2421539T1 (el) |
WO (1) | WO2010124141A1 (el) |
ZA (1) | ZA201107903B (el) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8524735B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US8815838B2 (en) | 2008-10-07 | 2014-08-26 | David C. Griffith | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
PL2346509T3 (pl) | 2008-10-07 | 2021-03-08 | Horizon Orphan Llc | Lewofloksacyna w postaci aerozolu dla zmniejszania stanu zapalnego płuc |
MX353288B (es) | 2009-09-04 | 2018-01-08 | Raptor Pharmaceuticals Inc | Uso de levofloxacina aerosolizada para el tratamiento de fibrosis quistica. |
US9572774B2 (en) | 2011-05-19 | 2017-02-21 | Savara Inc. | Dry powder vancomycin compositions and associated methods |
CN105163785A (zh) * | 2013-03-14 | 2015-12-16 | 森普拉制药公司 | 用于治疗呼吸道疾病的方法及其制剂 |
JP6966835B2 (ja) * | 2016-02-05 | 2021-11-17 | ホライズン オーファン リミテッド ライアビリティ カンパニー | 嚢胞性線維症のためのフルオロキノロン製剤 |
CN108849939B (zh) * | 2018-07-31 | 2021-02-19 | 广东省农业科学院植物保护研究所 | 盐酸左氧氟沙星在制备用于防治烟草青枯病的农药制剂中的应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005530704A (ja) * | 2002-03-05 | 2005-10-13 | トランセイブ, インク. | 細胞内感染を予防及び治療するための吸入システム |
RU2255757C1 (ru) * | 2004-06-22 | 2005-07-10 | Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" | Пептидное соединение, восстанавливающее функцию органов дыхания |
US7838532B2 (en) | 2005-05-18 | 2010-11-23 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
KR101488403B1 (ko) * | 2005-05-18 | 2015-02-04 | 엠펙스 파마슈티컬즈, 인코포레이티드 | 에어로졸화된 플루오로퀴놀론 및 이의 용도 |
US8834930B2 (en) | 2008-05-15 | 2014-09-16 | Novartis Ag | Pulmonary delivery of a fluoroquinolone |
US8815838B2 (en) | 2008-10-07 | 2014-08-26 | David C. Griffith | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
-
2010
- 2010-04-22 SG SG10201811494SA patent/SG10201811494SA/en unknown
- 2010-04-22 SI SI201031951T patent/SI2421539T1/sl unknown
- 2010-04-22 ES ES10767800T patent/ES2755754T3/es active Active
- 2010-04-22 PL PL10767800T patent/PL2421539T3/pl unknown
- 2010-04-22 EP EP10767800.5A patent/EP2421539B1/en active Active
- 2010-04-22 MX MX2011011190A patent/MX339077B/es active IP Right Grant
- 2010-04-22 NZ NZ596245A patent/NZ596245A/xx unknown
- 2010-04-22 KR KR1020117027809A patent/KR20120034626A/ko active Search and Examination
- 2010-04-22 AU AU2010238765A patent/AU2010238765B2/en active Active
- 2010-04-22 MY MYPI2011005063A patent/MY178871A/en unknown
- 2010-04-22 DK DK10767800T patent/DK2421539T3/da active
- 2010-04-22 PT PT107678005T patent/PT2421539T/pt unknown
- 2010-04-22 JP JP2012507400A patent/JP6179844B2/ja active Active
- 2010-04-22 HU HUE10767800A patent/HUE046595T2/hu unknown
- 2010-04-22 WO PCT/US2010/032128 patent/WO2010124141A1/en active Application Filing
- 2010-04-22 CA CA2759874A patent/CA2759874C/en active Active
- 2010-04-22 SG SG10201403512TA patent/SG10201403512TA/en unknown
- 2010-04-22 SG SG2011076932A patent/SG175288A1/en unknown
- 2010-04-22 CN CN2010800180220A patent/CN102427815A/zh active Pending
- 2010-04-22 LT LT10767800T patent/LT2421539T/lt unknown
- 2010-04-22 BR BRPI1006626A patent/BRPI1006626B8/pt active IP Right Grant
- 2010-04-22 CN CN201610900988.6A patent/CN107050032A/zh active Pending
- 2010-04-22 RU RU2011145430/15A patent/RU2535056C2/ru active
-
2011
- 2011-10-21 US US13/278,706 patent/US20120035166A1/en not_active Abandoned
- 2011-10-23 IL IL215777A patent/IL215777A/en active IP Right Grant
- 2011-10-24 CL CL2011002649A patent/CL2011002649A1/es unknown
- 2011-10-29 ZA ZA2011/07903A patent/ZA201107903B/en unknown
- 2011-11-02 CO CO11148624A patent/CO6450642A2/es not_active Application Discontinuation
-
2015
- 2015-10-09 JP JP2015201285A patent/JP6228580B2/ja not_active Expired - Fee Related
-
2019
- 2019-10-28 HR HRP20191951TT patent/HRP20191951T1/hr unknown
- 2019-11-06 CY CY20191101155T patent/CY1122525T1/el unknown
-
2020
- 2020-02-20 US US16/796,525 patent/US20210015811A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122525T1 (el) | Μεθοδοι θεραπειας μιας πνευμονικης βακτηριακης λοιμωξης με τη χρησιμοποιηση φθορο-κινολονων | |
CY1124086T1 (el) | Παραγωγα 3-τετραζολυλ-βενζεν-1,2-δισουλφοναμιδιου ως αναστολεις μεταλλο-βητα-λακταμασης | |
UY38553A (es) | Inhibidores de cdk2 | |
CY1121792T1 (el) | Ετεροκυκλικη ενωση | |
CY1121724T1 (el) | Ενωσεις για την αντιμετωπιση καρκινου | |
CY1121847T1 (el) | Παραγωγα 1-((3-((1-πιπεραζινυλο)καρβονυλο)φαινυλο)μεθυλο)-2,4(1η,3η)-κιναζολινοδιονης ως αναστολεις parp για τη θεραπεια του καρκινου | |
BR112013010018A2 (pt) | inibidores de cdk | |
CR20120053A (es) | Compuestos y metodos inhibidores de jak de pirazolopirimidina | |
CY1116383T1 (el) | Αντιβακτηριακες ενωσεις | |
BR112013017974A2 (pt) | inibidores de pirimidina girase e topoisomerase iv | |
CR20110195A (es) | Compuestos heteroaromáticos espirocíclicos fusionados para el tratamiento de infecciones bacterianas | |
CY1119842T1 (el) | Συντηγμενες τρικυκλικες ετεροκυκλικες ενωσεις ως αναστολεις ιντεγκρασης hiv | |
TR201802791T4 (tr) | Aril ve heteroaril füzyonlu laktamlar. | |
UY34451A (es) | Derivados de uracilo como inhibidores de la quinasa axl y c-met | |
EA201590917A1 (ru) | АМИДЗАМЕЩЕННЫЕ ГЕТЕРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ, ПРИМЕНИМЫЕ В КАЧЕСТВЕ МОДУЛЯТОРОВ ОТВЕТОВ, ОПОСРЕДУЕМЫХ IL-12, IL-23 И/ИЛИ IFNγ | |
CY1123919T1 (el) | 1η-βενζιμιδαζολο-4-καρβοξαμιδια υποκατεστημενα με τεταρτοταγη ανθρακα στην 2-θεση ειναι ισχυροι αναστολεις parp | |
BR112012013349A2 (pt) | novos compostos tricíclicos | |
UY33227A (es) | Compuestos de pirrolopirimidina como inhibidores de la cdk4/6 | |
CR11803A (es) | Pirrolopiridinas como inhibidores de cinasa | |
EA201790923A1 (ru) | Производные бетулина | |
EA201270535A1 (ru) | Пуриновые производные, применимые в качестве ингибиторов hsp90 | |
BR112013023266A8 (pt) | Inibidores da girase tricíclicos | |
BR112017023959A2 (pt) | novos compostos de sulfonimidoilpurinona e derivados para o tratamento e profilaxia de infecção por vírus | |
EA201170722A1 (ru) | Лактамы в качестве ингибиторов бета-секретазы | |
CY1113197T1 (el) | Παραγωγα 5-υδροξυμεθυλ- οξαζολιδιν-2-ονης για την αντιμετωπιση βακτηριακων νοσων του εντερου |